Katie E Blise

7PUBLICATIONS
56CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer diagnosisInnate immunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 21, 2026
Increased Glucose Availability Sensitizes Pancreatic Cancer to Macrophage-Targeting Immunotherapies.

|Dec 25, 2025
A window trial in metastatic pancreatic ductal adenocarcinoma reveals resistance mechanisms to targeting the KRAS-MEK pathway.

Motoyuki Tsuda, Dove Keith, Colin J Daniel

|Aug 12, 2025
Myc and Kras cooperate in adult acinar cells to drive phenotypic heterogeneity, metastasis, and therapeutic resistance in a novel pancreatic cancer mouse model.

Isabel A English, Patrick J Worth, Kevin Alexander MacPherson-Hawthorne

|Apr 28, 2025
Post-transcriptional regulator HuR promotes immune evasion in pancreatic ductal adenocarcinoma.

Yifei Guo, Jennifer M Finan, Alexandra Q Bartlett

|Feb 21, 2024
Machine Learning Links T-cell Function and Spatial Localization to Neoadjuvant Immunotherapy and Clinical Outcome in Pancreatic Cancer.

Katie E Blise, Shamilene Sivagnanam, Courtney B Betts

|Nov 14, 2023
Machine learning links T cell function and spatial localization to neoadjuvant immunotherapy and clinical outcome in pancreatic cancer.

Katie E Blise, Shamilene Sivagnanam, Courtney B Betts

Pageof 2

Frequent Collaborators

5 joint publications

Shamilene Sivagnanam

5 joint publications

Lisa M Coussens

4 joint publications

Rosalie C Sears

3 joint publications

Jonathan R Brody